Immunitor has developed and currently manufactures seven products as means of preventing and/or treating viral infections such as HIV, hepatitis B and C, influenza, cancer, atherosclerosis/obesity, and a broad spectrum bacterial, fungal infections.

Immunitor's proprietary technology enables us to formulate any vaccine as an oral pill which is easy to administer, has low manufacturing cost, stable, safe, and effective.


Immunitor Relative Development Pipeline